Investing.com - Merck reported on Thursday first quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Merck announced earnings per share of €2.06 on revenue of €5.21B. Analysts polled by Investing.com anticipated EPS of €2.11 on revenue of €5.17B.
Merck shares are down 21% from the beginning of the year and are trading at €179.05 , down-from-52-week-high.They are under-performing the STOXX 600 which is down 8.89% from the start of the year.
Merck shares gained 2.75% in intra-day trade after the report.
Merck follows other major Healthcare sector earnings this month
Merck's report follows an earnings beat by Siemens Healthineers on Thursday, February 3, 2022, who reported EPS of €0.55 on revenue of €5.07B, compared to forecasts EPS of €0.505 on revenue of €4.9B.
Bayer had beat expectations on Tuesday with first quarter EPS of €1.26 on revenue of €11.12B, compared to forecast for EPS of €1.01 on revenue of €10.45B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar